Panelists emphasize the complexity of choosing among available third-line therapies, noting that no single option fits all patients. Clinical decision-making weighs efficacy, safety, quality of life, ...

Safety results showed no increase in immune-mediated adverse events (34.0% vs 38.4%) or treatment-related adverse events ...

TeleMAB requests nearly doubled post-Roe v Wade reversal, especially in states with abortion restrictions, highlighting increased demand for remote services. TeleMAB offers cost, privacy, and travel ...

The AMA is dedicated to reducing physician burnout, a significant part of which is influenced by inflation and recent cuts to Medicare. In the last 20 years, payment rates have declined 33%, putting a ...

Effective patient counseling is paramount for adherence as patients with obstructive sleep apnea (OSA) start looking to take ...

The FDA approved tezepelumab-ekko (TEZSPIRE; AstraZeneca/Amgen) on Friday as an add-on maintenance treatment in patients aged ...